MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2025 International Congress

    Movement-Disorders Focused Clinical Neuroscience Training for Psychiatry Residents: A Competency-Based Medical Education Model

    A. Seritan (San Francisco, USA)

    Objective: To illustrate a novel educational program model that can train psychiatrists to develop competencies in caring for patients with movement disorders such as Parkinson's…
  • 2025 International Congress

    The Role of Research and Genetics Educational Events in Parkinson’s Research: Overcoming Barriers in the Hispanic Community

    A. Coral-Zambrano, M. Rodriguez Violante, J. Orozco Velez, M. Inca Martinez, I. Mata, P. Hodges, R. de León (Miami, USA)

    Objective: To assess the impact of educational events that emphasize research and genetics as well as culturally adapted recruitment strategies on increasing Hispanic participation in…
  • 2025 International Congress

    Barriers To Physical Exercise Adherence In Individuals With Parkinson’s Disease: A Cross-Sectional Study

    S. Souza, G. Leveck, T. Christinelli, L. Paladini, V. Israel (Curitiba, Brazil)

    Objective: To identify the main self-reported barriers to PE adherence in individuals with PD. Background: Parkinson’s disease (PD) is a neurodegenerative syndrome that leads to…
  • 2025 International Congress

    Parkinson’s Disease Health Policy in 7 African Countries: Results of a Transforming Parkinson’s Care in Africa (TraPCAf) Review

    R. Morton, A. Rogers, H. Francis, M. Cham, J. Lumsdon, C. Dotchin, E. Hamid, A. Akpalu, S. Gugssa, B. Mushengezi, O. Ojo, N. Okubadejo, D. Sokhi, R. Walker, N. Fothergill-Misbah (Newcastle upon Tyne, United Kingdom)

    Objective: To determine the inclusion of Parkinson’s Disease (PD) in African health policy, and treatment recommendations in available national policy documents. Background: Neurological disorders are…
  • 2025 International Congress

    Screening for Neuronal Synuclein Disease (NSD) using cerebrospinal fluid (CSF) in the Parkinson Progression Marker Initiative (PPMI)

    J. Dimos, B. Mcmahon, L. Lemon, A. Siderowf, T. Simuni, C. Tanner, K. Marek, C. Coffey, T. Foroud, L. Chahine, E. Brown, T. Tropea, M. Kuhl, A. Bright, M. Totten, G. Antonopoulos, L. Heathers (New Haven, USA)

    Objective: To utilize a centralized screening paradigm for early stage NSD based on sequential olfactory dysfunction (measured by University of Pennsylvania Smell Identification test (UPSIT))…
  • 2025 International Congress

    A Phase I Study of TR-012001, a Nasal Levodopa, in Healthy Adult Japanese Male Subjects

    R. Ise, M. Kaneko, S. Haruta, Y. Sonoda, Y. Akiyoshi, C. Date, S. Nakano, T. Akagi, Y. Sumiyoshi, S. Kanazashi, I. Nagata, H. Fukase (Tokyo, Japan)

    Objective: To investigate the safety, tolerability, and pharmacokinetics of TR-012001, a nasal levodopa (LD), in healthy Japanese adult men with and without premedication with dopa…
  • 2025 International Congress

    Adaptive deep brain stimulation for tremor control in Parkinson’s disease

    A. Ramirez-Zamora, T. Herrington, M. Beudel, J. Ostrem, S. Little, L. Almeida, A. Fasano, T. Hassell, K. Mitchell, E. Moro, M. Gostkowski, N. Sarangmat, L. Tonder, Y. Tan, R. Summers, N. Morelli, H. Bronte-Stewart (Gainesville, USA)

    Objective: To evaluate clinical improvements in tremor following the implementation of adaptive deep brain stimulation (aDBS). Background: Alpha-beta (8-30Hz) based aDBS is a safe and…
  • 2025 International Congress

    Randomized Trial comparing Directional DBS with Ring-mode DBS in PD

    V. Sisodia, TR. Ten Brinke, H. Jergas, VJJ. Odekerken, D. Verbaan, JM. Dijk, M. Bot, M. Beudel, P. Munckhof, MT. Barbe, PR. Schuurman, RMA. de Bie (Amsterdam, Netherlands)

    Objective: To evaluate whether directional DBS is more effective in reducing PD motor symptoms and causes fewer stimulation-induced adverse effects (AE) than ring-mode DBS. Background:…
  • 2025 International Congress

    Improvements in Motor and Non-Motor Symptoms of Parkinson’s Disease in Those Treated with Photobiomodulation Plus Exercise: A Sham-Controlled Study

    A. Saltmarche, O. Hares, A. Liebert, B. Bicknell, M. Naeser, G. Heller, J. Sykes, K. Togeretz, A. Namini, G. Herkes (Toronto, Canada)

    Objective: To assess efficacy of photobiomodulation + exercise to improve Parkinson’s disease (PD) symptoms. The primary outcome measure was timed up-and-go (TUG) and other motor…
  • 2025 International Congress

    Correlations of catecholamine metabolites and alpha-synuclein by nigral stimulation in Parkinson’s disease model rat

    T. Yamamoto, R. Sakakibara, T. Uchiyama, S. Kuwabara (Chiba, Japan)

    Objective: We aimed to clarify the effects of substantia nigra (SN) stimulation on catecholamine levels and α-synuclein in PD model rats. Background: Catecholaminergic neurons are…
  • 1
  • 2
  • 3
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley